Dear Technology… you precocious little Minsk.
What are we going to do with you?
You replicate, expand and improve faster than we can keep up. In a few days time, 4G will be so yesterday. We use you for our own advancement and entertainment with the always underlying thought that someday you very well may trump us all a la some crazy real world version of Terminator.
In the world of medicine you have become quite useful and adept. You provide physicians and patients with valuable information about diseases and the means to treat them. Pharmaceutical companies can now globally reach millions of consumers in the language of their choice.
In parts of the world where the number of patients far exceeds the number of doctors available to treat them, a physician’s time is precious and limited. Again, technology, you come to our rescue, allowing for CME and new product information exchanges to happen quickly and electronically. No appointment necessary.
Patients benefit as well with the ability to access disease awareness and education sites across the globe. Armed with more information than many may actually need, they march into their doctor’s office with many, many questions. Oh so many questions!
Ah, but again you are wily and not easily bound to regulations and conventions of protocol. DTC is illegal in most countries. You know it and we know it, yet you refuse to adhere.
When a patient demands to see your internet content on Lipitor, you are uncontrollable. You always give up the goods. You provide branded programs and information without discrimination. Not once do you ask, where do you live and who regulates your access to this information?
Someone in India can Google a pharma brand name and pull up sites not controlled in India. These online brand discussions can in fact be undercover DTC. You are a naughty little devil.
Ah, technology, you are slippery as an eel. Your benefits in the field of medicine abound, yet you are uncontrollable.
What are we going to do with you?
Sincerely,
aiaTranslations
(Sherry Dineen)
No comments:
Post a Comment